Group One Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,310
| Closed | -$3.38K | – | 8616 |
|
|
2024
Q4 | $3.38K | Sell |
6,310
-5,384
| -46% | -$3.75K | ﹤0.01% | 6581 |
|
|
2024
Q3 | $20.6K | Buy |
11,694
+4,091
| +54% | +$5.71K | ﹤0.01% | 5217 |
|
|
2024
Q2 | $8.9K | Buy |
7,603
+4,838
| +175% | +$12.1K | ﹤0.01% | 5687 |
|
|
2024
Q1 | $25K | Buy |
+2,765
| New | +$26.9K | ﹤0.01% | 5257 |
|
|
2023
Q4 | – | Sell |
-5,094
| Closed | -$38.2K | – | 8389 |
|
|
2023
Q3 | $41K | Sell |
5,094
-17,915
| -78% | -$149K | ﹤0.01% | 5289 |
|
|
2023
Q2 | $250K | Sell |
23,009
-29,084
| -56% | -$249K | ﹤0.01% | 3710 |
|
|
2023
Q1 | $359K | Buy |
52,093
+49,574
| +1,968% | +$311K | ﹤0.01% | 3085 |
|
|
2022
Q4 | $10K | Sell |
2,519
-9,393
| -79% | -$46.2K | ﹤0.01% | 6031 |
|
|
2022
Q3 | $79K | Buy |
11,912
+4,300
| +56% | +$26.5K | ﹤0.01% | 5003 |
|
|
2022
Q2 | $37K | Sell |
7,612
-16,365
| -68% | -$99.5K | ﹤0.01% | 5823 |
|
|
2022
Q1 | $224K | Sell |
23,977
-8,500
| -26% | -$84.4K | ﹤0.01% | 4685 |
|
|
2021
Q4 | $386K | Buy |
32,477
+7,090
| +28% | +$81.9K | ﹤0.01% | 4412 |
|
|
2021
Q3 | $289K | Buy |
25,387
+25,132
| +9,856% | +$346K | ﹤0.01% | 4788 |
|
|
2021
Q2 | $5K | Sell |
255
-14,436
| -98% | -$232K | ﹤0.01% | 7789 |
|
|
2021
Q1 | $227K | Sell |
14,691
-16,365
| -53% | -$237K | ﹤0.01% | 4895 |
|
|
2020
Q4 | $379K | Buy |
31,056
+1,782
| +6% | +$24.8K | ﹤0.01% | 3523 |
|
|
2020
Q3 | $376K | Buy |
29,274
+20,089
| +219% | +$173K | ﹤0.01% | 3100 |
|
|
2020
Q2 | $93K | Sell |
9,185
-6,682
| -42% | -$61.5K | ﹤0.01% | 3965 |
|
|
2020
Q1 | $129K | Sell |
15,867
-598
| -4% | -$5.18K | ﹤0.01% | 3101 |
|
|
2019
Q4 | $142K | Sell |
16,465
-22,018
| -57% | -$124K | ﹤0.01% | 3411 |
|
|
2019
Q3 | $237K | Buy |
38,483
+8,136
| +27% | +$65.7K | ﹤0.01% | 2958 |
|
|
2019
Q2 | $504K | Sell |
30,347
-50,828
| -63% | -$883K | ﹤0.01% | 2121 |
|
|
2019
Q1 | $1.36M | Buy |
81,175
+21,756
| +37% | +$313K | 0.02% | 1197 |
|
|
2018
Q4 | $682K | Buy |
59,419
+35,318
| +147% | +$715K | 0.01% | 1785 |
|
|
2018
Q3 | $964K | Buy |
+24,101
| New | +$686K | 0.01% | 1728 |
|
|
2018
Q2 | – | Sell |
-30,686
| Closed | -$680K | – | 5570 |
|
|
2018
Q1 | $469K | Buy |
30,686
+29,491
| +2,468% | +$702K | ﹤0.01% | 2111 |
|
|
2017
Q4 | $39K | Buy |
+1,195
| New | +$32.2K | ﹤0.01% | 3855 |
|
Group One Trading's MRNS Position: Q1 2025 in Review
Group One Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 6,310 shares — an estimated $3.38K sold.
Group One Trading first reported a position in MRNS in Q4 2017 and held it in 27 quarters. The position peaked at $1.36M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Group One Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Group One Trading sold 6,310 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $3.38K.
- Group One Trading first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 27 quarters.
- Group One Trading's Marinus Pharmaceuticals, Inc position peaked at $1.36M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.